PAPER Sahyouni M, Casey B 3rd, Carpenter Z, Estrella F, Okafor C
SEARCH RESULTS
340 RESULTS
PAPER Arora H, Javed B, Kutikuppala LV, Chaurasia M, Khullar K, Kannan S, Golla V
ST2 levels and neurodegenerative diseases: is this a significant relation?
Ann Med Surg (Lond). 2024 May;86(5):2812-2817. Epub 2024 Mar 12 PubMed.PAPER Warren A
The relationship between gender differences in dietary habits, neuroinflammation, and Alzheimer's disease.
Front Aging Neurosci. 2024;16:1395825. Epub 2024 Apr 17 PubMed.PAPER Brown CS, Ning X, Money A, Alford M, Pan Y, Miller M, Lohman M
Trends in cause-specific mortality among persons with Alzheimer's disease in South Carolina: 2014 to 2019.
Front Aging Neurosci. 2024;16:1387082. Epub 2024 Apr 17 PubMed.PAPER Xu Y, Xu M, Zhou C, Sun L, Cai W, Li X
Ferroptosis and its implications in treating cognitive impairment caused by aging: A study on the mechanism of repetitive transcranial magnetic stimulation.
Exp Gerontol. 2024 May 6;192:112443. PubMed.PAPER Gouveia Roque C, Phatnani H, Hengst U
The broken Alzheimer's disease genome.
Cell Genom. 2024 May 8;4(5):100555. Epub 2024 May 1 PubMed.PAPER He M, Zhang X, Ran X, Zhang Y, Nie X, Xiao B, Lei L, Zhai S, Zhu J, Zhang J, Li R, Liu Z, Zhu Y, Dai Z, He Z, Feng J, Zhang C
Black Phosphorus Nanosheets Protect Neurons by Degrading Aggregative α-syn and Clearing ROS in Parkinson's Disease.
Adv Mater. 2024 May 2;:e2404576. PubMed.PAPER Smith DM, Aggarwal G, Niehoff ML, Jones SA, Banerjee S, Farr SA, Nguyen AD
Biochemical, Biomarker, and Behavioral Characterization of the GrnR493X Mouse Model of Frontotemporal Dementia.
Mol Neurobiol. 2024 May 2; PubMed.Steven Smith
Bénédicte Hurez
Puteaux, France
Rafael Godoy
France
PAPER Qi WY, Sun Y, Guo Y, Tan L
Associations of sleep disorders with serum neurofilament light chain levels in Parkinson's disease.
BMC Neurol. 2024 May 1;24(1):147. PubMed.PAPER Chen H, Wang X, Chang Z, Zhang J, Xie D
Genetic causal relationship between multiple immune cell phenotypes and Parkinson's disease: a two sample bidirectional Mendelian randomization study.
J Neurophysiol. 2024 May 1; PubMed.PAPER Singh P, Belliveau P, Towle J, Neculau AE, Dima L
Edaravone Oral Suspension: A Neuroprotective Agent to Treat Amyotrophic Lateral Sclerosis.
Am J Ther. 2024 May-Jun 01;31(3):e258-e267. PubMed.PAPER Hudgins AD, Zhou S, Arey RN, Rosenfeld MG, Murphy CT, Suh Y